Data Is a Big Deal in Parkinson's Research. Here's Why. | FoxFlash August 2019

Ask the PhD: Big Data, Better Answers Why does data matter in Parkinson's disease (PD)? Two staff scientists from The Michael J. Fox Foundation (MJFF) talk about the data sets we're building through our Parkinson's Progression Markers Initiative and other studies to help us understand what causes PD and why it progresses. Watch the Video > What's on Your Mind? Thinking and Memory Problems in Parkinson's Hear expert discussion and ask your questions in our Third Thursdays Webinar series. September 19, 2019 at 12 p.m. ET Two Emerging Targets You Might Not Know About As part of our Ask the PhD series, an MJFF staff scientist answers questions about PINK1 and parkin, two important targets in our portfolio. Learn from an Expert > Make Your Voice Heard on Parkinson's Advocacy Day On Tuesday, September 10, join members of our community for Parkinson's Advocacy Day and tell your lawmakers what matters to you when it comes to research funding and access to treatments. Get Involved > Ask the MD: Stem Cells and Parkinson's Disease Scientists are using stem cells to learn about PD and develop treatments. Dr. Rachel Dolhun discusses the potential in stem cells, and ongoing work to evaluate their safety and benefit. See More > How Reliable Is Self-reported Data? Findings from a University of Rochester study supported by MJFF are lending confidence to self-reported data around difficult-to-diagnose atypical parkinsonisms, including Lewy body dementia, multiple system atrophy and progressive supranuclear palsy. Continue Reading > What's Your Story? As our community grows, so too do the friendships that hold it together. Tell us your stories about the MJFF connections you've made through research participation, fundraising, support groups and everything in between. Share Your Story >